[New method for analysis of target molecule in gastrointestinal carcinoma--from the choice of ATP7B as a target molecule for overcoming drug resistance through the development of an inhibitor against ATP7B].
Takebayashi
Yuji
Y
Department of Surgery II, Fukushima Medical School.
Kanzaki
Atsuko
A
Higashimoto
Masashi
M
Sugeno
Hidekazu
H
Takenoshita
Seiichi
S
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors* / Q000096:biosynthesis* / Q000235:genetics; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D027682:Cation Transport Proteins / Q000037:antagonists & inhibitors* / Q000096:biosynthesis* / Q000235:genetics; D002945:Cisplatin / Q000008:administration & dosage; D000073840:Copper-Transporting ATPases; D004317:Doxorubicin / Q000008:administration & dosage; D019008:Drug Resistance, Neoplasm; D005472:Fluorouracil / Q000008:administration & dosage; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008264:Macrophages / Q000378:metabolism
D027682:Cation Transport Proteins; D004317:Doxorubicin; D000251:Adenosine Triphosphatases; C000612464:ATP7B protein, human; D000073840:Copper-Transporting ATPases; D002945:Cisplatin; D002955:Leucovorin; D005472:Fluorouracil